|
Oct 9
|
Tonix Pharma Enhances Drug Development with AI Partnership
|
|
Oct 8
|
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
|
|
Aug 6
|
Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens
|
|
Jul 30
|
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
|
|
Jul 25
|
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
|
|
Jul 24
|
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
|
|
Jun 27
|
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
|
|
Jun 26
|
Tonix Pharmaceuticals Announces Proposed Public Offering
|
|
Jun 26
|
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
|
Jun 25
|
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
|
|
Jun 21
|
7 F-Rated Penny Stocks to Avoid This June
|
|
Jun 20
|
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
|
|
Jun 18
|
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
|
|
Jun 18
|
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
|
|
May 22
|
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
|
|
May 21
|
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia
|
|
Apr 29
|
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
|
|
Apr 29
|
TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…
|
|
Apr 24
|
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
|
|
Feb 29
|
Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia
|